On July 14, 2025, the Food and Drug Administration (FDA or Agency) held a public meeting to discuss proposed recommendations for the reauthorization of the Prescription Drug User Fee Act (PDUFA) for fiscal years (FYs) 2028 through 2032.
Similar Posts
Scientific Protein Laboratories, LLC – 712578 – 10/10/2025
CGMP/Active Pharmaceutical Ingredient (API)/AdulteratedFDA Roundup: March 12, 2024
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.Absolutely Natural – 715690 – 12/30/2025
CGMP/Finished Pharmaceuticals/AdulteratedVerified Clinical Benefit | Cancer Accelerated Approvals
This listing includes accelerated approvals (AAs) for malignant hematology and oncology indications with postmarketing trials that have verified clinical benefit and for which traditional approval has been subsequently granted for the specific indication.Healwell Homeo Private Limited – 706206 – 06/12/2025
CGMP/Finished Pharmaceuticals/AdulteratedBornstein Seafoods Inc Recalls Cooked & Peeled Ready-To-Eat Coldwater Shrimp Meat Because of Possible Health Risk
June 10, 2025, Bornstein Seafoods of Bellingham, Washington is recalling 44,550 Lbs. of Cooked & Peeled Ready-To-Eat Coldwater Shrimp Meat (see table below for multiple lot codes) because it has the potential to be contaminated with Listeria monocytogenes, an organism which can cause serious and som